Gilead to halt phase III study of leukemia drug

Singapore: Gilead Sciences plans to halt phase III study evaluating idelalisib in previously-treated chronic lymphocytic...

October 10, 2013 | Thursday | News
Sihuan, NeuroVive to develop heart and brain products

Singapore: Sihuan Pharmaceutical entered into a collaboration agreement with NeuroVive Pharmaceutical to develop two in...

November 21, 2012 | Wednesday | News
Bioxyne to report COPD trial results in June

Singapore: Australian company Bioxyne closed its 320-patient study, which was designed to evaluate the efficacy and safe...

May 29, 2012 | Tuesday | News
MicuRx next gen antibiotic gets US patent

Singapore: MicuRx Pharmaceuticals, a privately-held biopharmaceutical company developing next-generation antibiotics, ha...

May 24, 2012 | Thursday | News
MedImmune, UCSF enter 3-year R&D deal

Singapore: MedImmune, the global biologics R&D arm of AstraZeneca, has entered into a three-year collaboration with ...

February 18, 2014 | Tuesday | News
Biogen to commercialize MS therapies in Asia

Singapore: Belgium based pharmaceutical company UCB and global pharmaceutical company, Biogen, have entered into an agre...

February 11, 2014 | Tuesday | News
BD launches Cell Analyzer to enhance drug discovery

Singapore: BD Biosciences, a global medical technology company, has launched BD LSRFortessa X-20 Cell Analyzer, to deliv...

July 11, 2013 | Thursday | News
Viralytics melanoma study shows +ve results

Singapore: Assistant Professor (Dr) Robert H I Andtbacka presented a summary of his ongoing study with Viralytics' Cavat...

March 25, 2013 | Monday | News
India, EU firms fight 'epidemic of drug-resistance'

Singapore: India-based Orchid Pharma entered into a strategic partnership with Europe-based Allecra Therapeutics to deve...

April 19, 2013 | Friday | News
CoDa Therapeutics raises $19.8 mn from Russian firm

Singapore: CoDa Therapeutics has raised an additional $19.8 million (NZ$24.5 million) from Russian investment firm Rusna...

August 24, 2012 | Friday | News
Chugai seeks nod for breast cancer drug in Japan

Singapore: Japanese multinational Chugai Pharmaceutical has filed a new drug application to the Ministry of Health, Labo...

February 1, 2013 | Friday | News
Viralytics presents +ve results of phase II Cavatak trial

Singapore: Viralytics reported strong interim results from its phase II clinical trial of Cavatak treatment in late stag...

July 19, 2013 | Friday | News
Competition intensifies for type 2 diabetes drugs

Singapore: The global pre-diabetes population is three times the size of the current diabetes patient population and the...

August 28, 2013 | Wednesday | Analysis
FDA approval gives new hope to Multiple Sclerosis patients

Singapore: Genzyme, a Sanofi company, received approval from the US FDA for AUBAGIO (teriflunomide) as a new once-daily,...

September 13, 2012 | Thursday | News
TaiGen files NDA for Nemonoxacin in Taiwan, China

Singapore: Taiwan's TaiGen Biotechnology has submitted New Drug Application (NDA) for the oral formulation of nemonoxaci...

May 16, 2013 | Thursday | News
Verinata Health joins hands with Teva in Israel

Singapore: Illumina announced that Teva Pharmaceutical has signed an exclusive agreement with Verinata Health, an Illumi...

July 2, 2013 | Tuesday | News
Merck Serono starts Phase III non-small cell lung cancer drug trial

Singapore: Global biopharmaceutical firm Merck Serono has initiated international Phase III trial of its investigational...

April 9, 2014 | Wednesday | News
Pradaxa gets EU approval for DVT

Singapore: Boehringer Ingelheim has recieved Euroean approval for Pradaxa (dabigatran etexilate) for the treatment and p...

June 10, 2014 | Tuesday | Regulatory

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls